Search

Biomonitoring is used increasingly as an indicator and quantitative measure of exposure; however, there is a large gap in interpreting and communicating biomonitoring results to study participants. Two separate, national biomonitoring initiatives are under way in Canada; the household recruitment-based Canadian Health Measures Survey (CHMS) and the clinic recruitment-based Maternal-Infant Research on Environmental Chemicals (MIREC) Study. The CHMS provides participants with the option to receive all their results, but this option is not provided to MIREC participants. The approach to reporting results to participants depends on the availability of reference ranges and guidelines for which tissue concentrations may be interpreted as being elevated or associated with increased health risks, how participants are recruited, unique vulnerabilities of the population, legislation governing access to personal information, and decisions of research ethics committees. It is the researchers' responsibility to present the best case for their approach and, once the decision has been made, to inform participants about access to their results through the consent process. [ABSTRACT FROM AUTHOR]

Background: The Maternal-Infant Research on Environmental Chemicals (MIREC) Study was established to obtain Canadian biomonitoring data for pregnant women and their infants, and to examine potential adverse health effects of prenatal exposure to priority environmental chemicals on pregnancy and infant health., Methods: Women were recruited during the first trimester from 10 sites across Canada and were followed through delivery. Questionnaires were administered during pregnancy and post-delivery to collect information on demographics, occupation, life style, medical history, environmental exposures and diet. Information on the pregnancy and the infant was abstracted from medical charts. Maternal blood, urine, hair and breast milk, as well as cord blood and infant meconium, were collected and analysed for an extensive list of environmental biomarkers and nutrients. Additional biospecimens were stored in the study's Biobank. The MIREC Research Platform encompasses the main cohort study, the Biobank and follow-up studies., Results: Of the 8716 women approached at early prenatal clinics, 5108 were eligible and 2001 agreed to participate (39%). MIREC participants tended to smoke less (5.9% vs. 10.5%), be older (mean 32.2 vs. 29.4 years) and have a higher education (62.3% vs. 35.1% with a university degree) than women giving birth in Canada., Conclusions: The MIREC Study, while smaller in number of participants than several of the international cohort studies, has one of the most comprehensive datasets on prenatal exposure to multiple environmental chemicals. The biomonitoring data and biological specimen bank will make this research platform a significant resource for examining potential adverse health effects of prenatal exposure to environmental chemicals., (© 2013 John Wiley & Sons Ltd and Her Majesty the Queen in Right of Canada. Reproduced with the permission of the Minister of Health.)

Objectives: We present total mercury (THg) in blood of Canadians 6-79 years of age from the first to-date nationally-representative survey, the Canadian Health Measures Survey (CHMS). This analysis is particularly relevant in the context of recent changes to Health Canada's blood Hg guidance values., Methods: We used data from cycle 1 (2007-2009) of the CHMS, in particular focussing on 5,319 respondents aged 6-79 years for whom blood THg data were available. We calculated descriptive statistics of blood Hg levels and analyzed the associations between blood THg levels and relevant variables. We also compared blood THg levels to existing Health Canada blood Hg guidance values., Results: The geometric mean blood THg level of the Canadian population was 0.69 µg/L (95% CI 0.56-0.86 µg/L). The majority (97.8%) of Canadian women aged 16-49 years, including pregnant women, had blood Hg values below the provisional HC blood guidance value of 8 µg/L. Mean blood THg levels were significantly higher in the "other or mixed" (1.14 µg/L, p=0.0003) and Asian (1.41 µg/L, p=0.0476) groups compared to those who self-identified as solely Caucasian (0.62 µg/L). There was however no significant difference between participants self-identified as Aboriginal Canadians versus Caucasians (0.56 µg/L vs 0.62 µg/L, p=0.2902).Fish and shellfish consumption significantly influenced blood Hg levels, as did alcohol consumption and the presence of dental amalgams., Conclusion: This paper presents the first description of blood THg levels in the general Canadian population. These findings will serve as a national baseline for monitoring future changes should they arise.

Hair samples continue to be used extensively for biomonitoring of mercury (Hg) exposure. Routine methods require a bundle of 100-150 hair strands and involve chemical digestion. Recently, Hg analyzers that combine combustion, gold amalgamation, and atomic absorption spectrometry (C-GA-AAS) became commercially available. This method was shown to provide quick and sensitive measurements in solid samples such as hair. The objective of this study was to validate C-GA-AAS for measuring total Hg in single hair strands as an alternative method for Hg biomonitoring. Hair samples from 12 women with a wide range of Hg exposure were obtained from two projects conducted in Brazil and Canada. A 1:1 relationship was observed between C-GA-AAS and the established cold vapor atomic absorption spectrometry (CV-AAS) for analysis of 1-cm segments from a bundle of hair. For individual hair variability, the average relative standard deviation (RSD) of Hg between hair strands was 6.5 +/- 2.8%, thus justifying the use of single hair strand for biomonitoring. With a limit of quantification of 0.10 ng of total Hg, a single hair strand can be used to assess monthly exposure. This technique will facilitate routine biomonitoring and thus help prevent Hg poisoning among the public.